Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Artificial Intelligence
Social Media
Donald Trump
NATO
Taxes
European Union
Education
Soccer
Cryptocurrency
Stock Markets
Climate Change
Corruption
Eyewire+ image

News from Eyewire+

Information about Eyewire+

Where is Eyewire+ located?Eyewire+'s Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Eyewire+ News

Startup That Makes Robots For Cataract Surgery Raises $125 Million In Second-Largest Fundraise For A Surgical Robotics Firm

Startup That Makes Robots For Cataract Surgery Raises $125 Million In Second-Largest Fundraise For A Surgical Robotics Firm

100% Center coverage: 2 sources
Millions of people get cataract surgery every year. What if a robot could do it better than humans?See the Story
A Large Genome-Wide Association Study of Age-Related Macular Degeneration Highlights Contributions of Rare and Common Variants

A Large Genome-Wide Association Study of Age-Related Macular Degeneration Highlights Contributions of Rare and Common Variants

100% Center coverage: 2 sources
Iris Heid, Gonçalo Abecasis, Sudha Iyengar and colleagues report the results of a large genome-wide association meta-analysis of macular degeneration based on over 43,000 subjects. They identify 16 new risk loci, including some very rare coding variants. Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with limited therapeutic options. Here we report on a study of >12 million variants, including 1…See the Story
Viatris’ Presbyopia Drug Clears Second Phase III Trial

Viatris’ Presbyopia Drug Clears Second Phase III Trial

There are only two therapies approved for presbyopia in the US.The post Viatris’ presbyopia drug clears second Phase III trial appeared first on Clinical Trials Arena.See the Story

Stuart Reports Initial Outcomes From Trial of Ophthalmic Solution for DED

Stuart Therapeutics has reported initial findings from its Phase III trial of ST-100 ophthalmic solution for dry eye disease (DED).The post Stuart reports initial outcomes from trial of ophthalmic solution for DED appeared first on Clinical Trials Arena.See the Story

Valorum Biologics to Commercialize Formycon’s Eylea Biosimilar FYB203 in US and Canada

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema, macular edema following retinal vein occlusion, and visual impairment due to myopic choroidal neovascularization.United States · United StatesSee the Story

Qlaris Bio to Present New Clinical and Preclinical Data on QLS-111 at 2025 World Glaucoma Congress

Qlaris Bio announced that new data from studies of its lead investigational compound QLS-111 will be presented at the 2025 World Glaucoma Congress (WGC). This will include an oral presentation on clinical data from the recently completed QC-111-201 “Osprey” and QC-111-203 “Apteryx” Phase 2 studies in patients with primary open-angle glaucoma  and ocular hypertension, as well as two poster presentations featuring additional data on QLS-111. The 2…Maryland · MarylandRead Article

Johnson & Johnson launches Acuvue Oasys MAX 1-day multifocal toric contact lens

Johnson & Johnson introduces Acuvue Oasys MAX 1-Day multifocal toric lenses, the first and only daily disposable contact lens for astigmatism and presbyopia.United States · United StatesSee the Story

France First in EU to Reimburse Hoya MiYOSMART Lens for Childhood Myopia

France will begin reimbursing Hoya Vision Care’s MiYOSMART myopia control spectacle lenses for eligible children starting July 1. This move makes France as the first country in the European Union to provide public coverage for the lenses. The decision follows a review by the French Health Authority (HAS). It aims to expand access to treatment for children with high (-6.00D or more) and/or rapidly progressing myopia (worsening by -0.50D or more p…France · FranceRead Article

New York Eye and Ear Infirmary of Mount Sinai Opens First Comprehensive Center for Refractive Solutions in New York

The New York Eye and Ear Infirmary of Mount Sinai (NYEE) has announced the launch of the Center for Refractive Solutions, a facility dedicated to comprehensive vision correction services. Located at 310 East 14th Street in Lower Manhattan, the newly renovated space marks the first center of its kind in New York City and one of only a few in the nation to offer an all-in-one destination for advanced refractive care. According to NYEE, the center …Maryland · MarylandRead Article

PolyActiva Appoints Jerry St. Peter as CEO; Secures Financing to Advance Prezia Technology Platform

100% Center coverage: 1 sources
PolyActiva announced two milestones in its next phase of growth: the appointment of biopharmaceutical executive Jerry St. Peter as CEO and board director, and the successful close of a $25M Series C funding round led by an Australian Sovereign Wealth Fund with continued strong support from Brandon Capital. Mr. St. Peter succeeds current CEO Vanessa Waddell, who will remain as part of the company’s executive leadership team in the role of chief s…Melbourne, Australia · MelbourneSee the Story

Aldeyra Therapeutics Resubmits Reproxalap NDA in Dry Eye Disease

The company believes results from a recent phase 3 chamber trial fulfill the FDA’s requests in the Complete Response Letter received in April of 2025.Layoffs · United StatesSee the Story

Breaking News Topics Related to Eyewire+

AMD icon

AMD

Salt Lake County icon

Salt Lake County

Utah icon

Utah

Canada icon

Canada

Maryland icon

Maryland

United States icon

United States

News
For You
SearchBlindspotLocal